Cargando…
Twelve-month clinical results from the new cobalt-chromium sirolimus-eluting dedicated bifurcation stent BiOSS LIM C Registry
INTRODUCTION: Percutaneous coronary interventions (PCI) in bifurcations are still challenging and are associated with higher risks of periprocedural complications as well as restenosis and stent thrombosis. The aim of this paper was to summarize 12 months of clinical results of the prospective, firs...
Autores principales: | Gil, Robert J., Kern, Adam, Pawłowski, Tomasz, Bil, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074308/ https://www.ncbi.nlm.nih.gov/pubmed/37034511 http://dx.doi.org/10.5114/aoms.2020.92974 |
Ejemplares similares
-
Rationale and design of the randomized, multicenter, open-label, controlled POLBOS 3 trial aimed to compare regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM C stent
por: Gil, Robert J., et al.
Publicado: (2019) -
Angiographic Restenosis in Coronary Bifurcations Treatment with Regular Drug Eluting Stents and Dedicated Bifurcation Drug-Eluting BiOSS Stents: Analysis Based on Randomized POLBOS I and POLBOS II Studies
por: Gil, Robert J., et al.
Publicado: (2020) -
12-month intravascular ultrasound observations from BiOSS® first-in-man studies
por: Gil, Robert J., et al.
Publicado: (2016) -
Comparative analysis of lumen enlargement mechanisms achieved with the bifurcation dedicated BiOSS(®) stent versus classical coronary stent implantations by means of provisional side branch stenting strategy: an intravascular ultrasound study
por: Gil, Robert J., et al.
Publicado: (2013) -
Very Late Pathological Responses to Cobalt–Chromium Everolimus‐Eluting, Stainless Steel Sirolimus‐Eluting, and Cobalt–Chromium Bare Metal Stents in Humans
por: Mori, Hiroyoshi, et al.
Publicado: (2017)